Tritium uptake, half-lives and radiation doses in tissues of cancer patients treated with tritiated 2-methyl-1:4-naphthaquinol diphosphate.
D000818:Animals; D005260:Female; D006801:Humans; D008297:Male; D009285:Naphthoquinones / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism* / Q000532:radiotherapy; D011817:Rabbits; D014316:Tritium / Q000378:metabolism* / Q000627:therapeutic use
D009285:Naphthoquinones; D014316:Tritium